![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/06/Simeprevir-is-an-Orally-Active-HCV-NS34A-Protease-Inhibitor-2021-06-19.jpg)
Hepatitis C is a blood-borne infection that can ultimately result in severe liver diseases, including fibrosis, cirrhosis, and hepatocellular carcinoma.…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/01/AG-1478-is-a-Selective-EGFR-Tyrosine-Kinase-Inhibitor-2020-01-16.jpg)
Epidermal growth factor receptor (EGFR) is a transmembrane protein and a member of the ErbB receptor family. Specifically, EGFR is…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/12/BMS-986144-is-a-Third-Generation-NS34A-Protease-Inhibitor-2020-01-07.jpg)
Hepatitis C virus (HCV) is a human pathogen with high morbidity. The HCV NS3/4A protease is essential for viral replication…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/06/HZ-1157-is-a-HCV-NS34A-Protease-Inhibitor-2020-07-01.jpg)
The major cause of chronic liver disease is the Hepatitis C virus (HCV). HCV is able to establish a chronic…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/04/TTP-8307-a-Broad-Spectrum-Inhibitor-of-Enteroviruses-Inhibitor-Inhibits-Viral-RNA-Synthesis-and-Targets-OSBP-2020-04-18.jpg)
Enteroviruses comprise several pathogens. They cause a large variety of clinical manifestations that range from mild illnesses to more serious or…